本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

1.20
-0.0300-2.44%
盤後1.200.00000.00%19:53 EDT
成交量:34.95萬
成交額:42.70萬
市值:1,542.37萬
市盈率:-1.10
高:1.27
開:1.27
低:1.18
收:1.23
資料載入中...
2020/03/27

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals